Your browser doesn't support javascript.
loading
Mn2+-modified black phosphorus nanosensor for detection of exosomal microRNAs and exosomes.
Xia, Qing; Zheng, Jintao; Bu, Jianlan; Li, Rui; Li, Xinxin; Fan, Shuting; Ling, Kai; Jiang, Hongyan.
Afiliação
  • Xia Q; Department of Pharmacy, Shantou University Medical College, Shantou, 515041, China.
  • Zheng J; Department of Pharmacy, Shantou University Medical College, Shantou, 515041, China.
  • Bu J; Department of Pharmacy, Shantou University Medical College, Shantou, 515041, China.
  • Li R; Department of Pharmacy, Shantou University Medical College, Shantou, 515041, China.
  • Li X; Department of Gastrointestinal Surgery, 1st Affiliated Hospital of Shantou University Medical College, Shantou, 515041, China.
  • Fan S; Department of Pharmacy, Shantou University Medical College, Shantou, 515041, China.
  • Ling K; Department of Pharmacy, Shantou University Medical College, Shantou, 515041, China. kailing@stu.edu.cn.
  • Jiang H; Department of Pharmacy, Shantou University Medical College, Shantou, 515041, China. hyjiang@stu.edu.cn.
Mikrochim Acta ; 190(8): 295, 2023 07 17.
Article em En | MEDLINE | ID: mdl-37458810
ABSTRACT
The development and performance of a DNA probe adsorbing Mn2+-modified black phosphorus (BP@Mn2+/DNA) hybrid nanosensor is reported that enables rapid detection of cancer-derived exosomal microRNAs (miRNAs) and exosomes. This two-dimensional (2D) nanosensor can spontaneously penetrate the lipid bilayer of exosome membranes owing to its ultra-thin geometry. Subsequently, the adsorbed probe specifically hybridizes with the target miRNA and then dissociates from the nanosensor surface, generating fluorescent signals. Therefore, the BP@Mn2+/DNA nanosensor can differentiate between colorectal cancer (CRC) cell-derived exosomes and those derived from intestinal epithelial cells through sensing of exosomal miRNAs. Furthermore, when the epithelial cell adhesion molecule (EpCAM) aptamer is adsorbed onto BP@Mn2+ instead of the miRNA probe, the nanosensor is able to distinguish exosomes derived from the plasma of CRC patients from those of healthy controls by the recognition ability of the EpCAM aptamer. By utilizing this nanosensor, we were able to effectively differentiate cancer-derived exosomes through the direct detection of miRNA-21 within the exosomes, as well as the identification of specific exosomal membrane proteins. This nanosensor design paves the way for the development of rapid and efficient cancer-derived exosomal miRNA and exosome biosensing nanoplatforms.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: MicroRNAs / Exossomos / Neoplasias Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: MicroRNAs / Exossomos / Neoplasias Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article